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OBJECTIVES We prospectively studied the prognostic value of predischarge dobutamine stress echocardi-
ography (DSE) in low-risk chest pain patients with a normal or nondiagnostic electrocar-
diogram (ECG) and a negative serial troponin T.
BACKGROUND Noninvasive stress testing is recommended before discharge or within 72 h in patients with
low-risk chest pain. The prognostic value of immediate DSE has not been studied in a
blinded, prospective fashion.
METHODS Patients presenting at the emergency room within 6 h of symptom onset and a normal or
nondiagnostic ECG were eligible. Dobutamine stress echocardiography was performed after
unstable coronary artery disease was ruled out by a standard rule-out protocol and a negative
serial troponin T; the occurrence of any new wall motion abnormality was considered positive.
Results were kept blinded. End points were cardiac death, myocardial infarction, rehospital-
ization for unstable angina or revascularization.
RESULTS In total, 377 patients were included. There were 2 deaths, 2 myocardial infarctions, 8
rehospitalization for unstable angina, and 10 revascularizations at six-month follow-up. The
end points occurred in 8/26 (30.8%) patients with a positive versus 14/351 (4.0%) patients
with a negative DSE (odds ratio, 10.7; 95% confidence interval, 4.0 to 28.8; p  0.0001). By
multivariate analysis, DSE remained a predictor of end points (p  0.0001).
CONCLUSIONS A predischarge DSE had important, independent prognostic value in low-risk, troponin
negative, chest pain patients. (J Am Coll Cardiol 2003;41:596–602) © 2003 by the
American College of Cardiology Foundation
The evaluation and management of patients presenting to
the emergency room with acute chest pain suggestive of
myocardial ischemia remains a challenge (1). In patients
with a conclusive electrocardiogram (ECG), management is
straightforward (2). However, the majority of patients with
chest pain as a presenting complaint will have a normal or
nondiagnostic ECG on presentation at the emergency room
(3). In these patients further evaluation is needed. Several
strategies have been proposed to improve decision-making
in such patients and to identify both high-risk patients who
should be admitted and low-risk patients who can be sent
home safely (4–6). The recommended and most widely
used strategy is the combination of an observation period,
serial ECG, and serial biochemical marker measurements,
usually followed by a stress test, either predischarge or
within 72 h at the outpatient clinic (7,8). More recently,
serial cardiac troponin T, a specific biochemical marker, has
been incorporated in such “rule-out” protocols (7,9–11).
While exercise electrocardiography is widely used before
discharge for its diagnostic and prognostic information
(8,12), it has important limitations, e.g., in patients with an
uninterpretable ECG and in patients unable to exercise
(8,13). An alternative approach in these patients is either
nuclear imaging or dobutamine stress echocardiography
(DSE) (7,8). Compared with exercise electrocardiography,
DSE does not depend on exercise performance or on
electrocardiographic changes for the detection of ischemia;
it has better sensitivity and specificity (14); earlier detection
of ischemia is possible according to the ischemic cascade
(15), and it provides information on cardiac anatomy and
left ventricular function (16). Nuclear imaging has a high
sensitivity and specificity (17), but is often not acutely
available, is costly, and it is not a bedside technique. In
contrast, DSE is an available bedside technique, with
sensitivity and specificity comparable to nuclear imaging
(14).
The diagnostic and prognostic value of DSE was dem-
onstrated in different patient populations, such as in patients
with known or suspected coronary artery disease (18) and
postmyocardial infarction (19). However, the prognostic
value of DSE for risk-stratification in low-risk patients with
chest pain before discharge from the emergency room is
unclear.
The aim of the present study was to evaluate the
prognostic value of a predischarge DSE in low-risk chest
pain patients, identified by a standard rule-out protocol and
a negative serial troponin T.
From the *Department of Cardiology, Academic Medical Center, Amsterdam, the
Netherlands; †Department of Cardiology, Medical Center Alkmaar, Alkmaar, the
Netherlands; ‡Department of Cardiology, VU Medical Center, Amsterdam, the
Netherlands; §Department of Clinical Chemistry, Academic Medical Center, Am-
sterdam, the Netherlands. Supported by the Dutch Heart Foundation (grant NHS
96.172).
Manuscript received May 7, 2002; revised manuscript received August 4, 2002,
accepted September 6, 2002.
Journal of the American College of Cardiology Vol. 41, No. 4, 2003
© 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00
Published by Elsevier Science Inc. doi:10.1016/S0735-1097(02)02897-8
METHODS
We conducted a prospective, double-blind, multicenter
study in low-risk patients presenting at the emergency room
with acute chest pain. The study was performed in accor-
dance with the principles set out in the declaration of
Helsinki (the procedures followed were in accordance with
institutional guidelines) and was approved by local ethics
committees on human research.
Patients: selection and management. Patients presenting
at the emergency room within 6 h of chest pain and a
normal or a nondiagnostic ECG were eligible for inclusion
in the admission cohort. Patients younger than 18 years,
patients who were incapable to give informed consent, and
patients with any of the following conditions at presentation
were not considered for inclusion: atrial fibrillation, conduc-
tion disturbances (second or third degree atrial-ventricular
block or new bundle branch block), severe uncontrolled
hypertension (180/120 mm Hg) despite adequate therapy,
severe heart failure, cardiomyopathy, resuscitation, and se-
rious noncardiac disease (e.g., infection and neoplastic
conditions), and pregnancy.
A total of 557 patients gave informed consent. The
management of these patients was according to the standard
protocols used in the three participating hospitals. In
general, patients remained under observation until at least
12 h after the onset of symptoms. Evaluation included
careful history taking, physical examination, serial 12-lead
ECGs, continuous rhythm monitoring, and serial cardiac
troponin T measurements. Serial ECGs were recorded
according to protocol directly on admission, after the
administration of sublingual nitrates, and during any new
episode of chest pain while the patient remained under
observation and before discharge. Troponin T was mea-
sured at admission (i.e., within 6 h of chest pain) and at 12 h
after the onset of chest pain. All patients received aspirin
300 mg on admission, unless they were already on aspirin or
when aspirin was contraindicated. Further patient manage-
ment, e.g., the decision to order additional tests, such as a
predischarge exercise ECG, admission to the hospital, or
subsequent therapy, was at the discretion of the attending
physician.
During the observation period, 119 patients were diag-
nosed with an acute coronary syndrome, and 34 patients had
other serious cardiac or noncardiac diagnoses. After ruling
out unstable coronary artery disease, including negative
serial cardiac troponin T (defined as peak-value  0.06
ng/ml at 6 and 12 h after the onset of symptoms), the
remaining 404 patients underwent a two-dimensional echo-
cardiography. Of these, 27 patients did not proceed to the
DSE because of a poor echocardiogram image (23 patients)
or the detection of an abnormality on the resting echocar-
diogram (4 patients). Thus, 377 patients completed the
predischarge DSE protocol (“stress echo cohort”), which
was performed within 24 h after admission (Fig. 1). The
DSE results were kept blinded to the attending physician,
the patient, or anyone involved in patient management.
Follow-up. The follow-up period of the stress echocardio-
gram cohort was six months.
The patients were discharged home with aspirin and a
beta-blocker (unless contraindicated), at least until the first
outpatient visit at four weeks after discharge. All patients
returned for a study follow-up visit at six months.
The primary end point was defined as the combination of
cardiac death, nonfatal acute myocardial infarction (AMI),
and rehospitalization for unstable angina (UA). The sec-
ondary end point was coronary revascularization procedure
(percutaneous transluminal coronary angioplasty or coro-
nary artery bypass grafting or the decision to perform
either). A combined end point was defined as the combi-
nation of primary and secondary end point.
In case any end point was reached, the patient’s cardiol-
ogist or general practitioner was consulted, and hospital
records or other documentation was collected to confirm the
diagnosis. In case of more than one cardiac event, the
following order was used: 1) cardiac death, 2) nonfatal
AMI, 3) rehospitalization for UA, 4) revascularization.
Abbreviations and Acronyms
AMI  acute myocardial infarction
CI  confidence interval
DSE  dobutamine stress echocardiography or
echocardiogram
UA  unstable angina
Figure 1. The admission cohort was formed by patients with chest pain
who met the inclusion criteria and gave informed consent (557 patients).
The observation period was uneventful, and serial cardiac troponin T was
negative in 404 patients. These patients were eligible to undergo dobut-
amine stress echocardiography. However, in 27 patients dobutamine stress
echocardiography could not be performed. The remaining 377 patients
underwent dobutamine stress echo cohort and were considered for further
analysis.
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Cardiac death was defined as death associated with
known or suspected AMI, life-threatening arrhythmia, or
pulmonary edema (based on clinical assessment, cardiac
isoenzymes, ECG, or autopsy). Unexpected death without
an identified noncardiac cause was also classified as cardiac
death. Nonfatal AMI was defined according to the World
Health Organization criteria, including a typical history,
defined changes on the ECG, and a rise in cardiac markers.
Rehospitalization for UA was defined as recurrent episode
of chest pain requiring hospital admission and intravenous
treatment with heparin and nitrates to relieve symptoms.
DSE. The DSE was performed according to the standard
protocol (13): dobutamine was infused intravenously based
on 3-min stages of 10, 20, 30, and 40 g/kg/min. Atropine
(0.25 to 1 mg intravenously) was given if the 85% of the age
predicted maximal heart rate was not achieved (i.e., target
heart rate) or other end points were not reached at peak
dobutamine dose. End points included severe and/or exten-
sive new wall motion abnormality, target heart rate, signif-
icant tachyarrhythmias, significant changes on the ECG,
severe chest pain, significant increase or decrease in blood
pressure (240/120 mm Hg or reduction of systolic pres-
sure  40 mm Hg), or any intolerable side effect. A
beta-blocker was administered intravenously to reverse the
effects, if they did not revert spontaneously and quickly after
stopping the infusion. For purpose of analysis, the left
ventricular wall was divided into 16 segments and scored
using a 4-point scale (1, normal; 2, hypokinesis; 3, akinesis;
and 4, dyskinesis) (20). Ischemia was not considered if
akinetic segments at rest became dyskinetic during stress
(21). The images of the DSE were compared off-line side by
side in quad screen format by two experienced investigators
without knowledge of the patients’ clinical data. In case of
disagreement, a majority decision was achieved by a third
investigator (J.H.C., O.K., R.B.). The results were dichot-
omized as either positive or negative for ischemia. A positive
DSE was defined as the occurrence of new wall motion
abnormality in at least one segment.
Electrocardiographic criteria. The ECG of the qualifying
episode of chest pain, the admission ECG, and subsequent
ECGs during the observation period were collected. One of
the authors (R. dW.), who was blinded to all clinical data,
reevaluated and scored the ECGs off-line as normal or
nondiagnostic (signs of left ventricular hypertrophy, bundle
branch block, prior AMI, or the presence of nonspecific
ST-segment abnormalities).
Statistical analysis. Univariate analysis for categorical vari-
ables was performed using chi-square test or Fisher exact
test where appropriate. Continuous variables were expressed
as mean  SD and were compared by the independent
samples t test. Stepwise multiple logistic regression analyses
were used to identify independent predictors regarding the
predefined primary and combined end point. In the logistic
regression model, criterion for entry of variables was set on
0.20, and criterion for removal was set on 0.25. Variables
included in this analysis were age 65 years, history of
coronary artery disease, prior use of aspirin, prior use of
beta-blocker, prior use of nitrate, and positive DSE. The
difference in risk was expressed as the odds ratio with the
corresponding 95% confidence intervals (CI).
A p value of  0.05 was considered statistically signifi-
cant. The SPSS statistical package (SPSS 10.01 for Win-
dows, SPSS Inc., Chicago, Illinois) was used for analysis.
RESULTS
Baseline characteristics. The baseline characteristics of
the DSE cohort are displayed in Table 1. Distribution of
variables was typical for a low-risk population at the
emergency room. Additional stress tests were ordered in
222/377 (59%).
DSE results. The mean time from admission to DSE
performance was 17.8  6.4 h. Atropine was administered
in 196/377 (52.0%) patients, of which 58/196 (29.6%) used
a beta-blocker. Dobutamine-atropine infusion increased
heart rate from 67  13 beats/min to 132  18 beats/min,
systolic blood pressure from 133  24 mm Hg to 139  29
mm Hg, and double (rate-pressure) product from 8,994 
2,447 mm Hg  beats/min to 18,458  4,809 mm Hg 
Table 1. Baseline Characteristics
Variables n  377
Age (yrs) mean  SD 56  12
Men 237 (58)
Onset of symptoms to admission (min), mean  SD 159  95
Risk factors:




Previous: 5 yrs 25 (7)
Previous: 5 yrs 86 (23)
Hypercholesterolemia 132 (35)
Family history of CAD 193 (51)
Documented CAD* 77 (20)
Acute myocardial infarction 59 (16)
Peripheral artery disease 50 (13)
Transient ischemic attack/cerebrovascular accident 25 (6)





Calcium antagonist 56 (15)
ACE inhibitor 43 (11)
Statin 66 (18)
Blood pressure and heart rate on admission:
Systolic blood pressure (mm Hg), mean  SD 146  25




Additional stress test 259 (69)
Values are all n (%) unless otherwise indicated. *Documented CAD defined as prior
acute myocardial infarction, revascularization, or documented coronary artery stenosis
(50%) on coronary angiogram; †Renal insufficiency defined as creatinine  200
mol/L.
ACE  angiotensin-converting enzyme; CAD  coronary artery disease.
598 Bholasingh et al. JACC Vol. 41, No. 4, 2003
Prognostic Value of Predischarge DSE February 19, 2003:596–602
beats/min. In 302/377 (80.1%) patients, the target heart rate
was achieved. In 75/377 (19.9%) patients, the protocol was
not completed because of the prespecified criteria: extensive
new wall motion abnormality (1 patient), electrocardio-
graphic changes (7 patients), chest pain (28 patients),
intolerable side effects (39 patients) such as arrhythmia and
severe hypertension or hypotension.
In total, 26/377 (6.9%) patients had positive DSE,
defined as the development of at least one segment of new
wall motion abnormality. The mean time between admis-
sion and DSE was similar for patients with positive versus
negative DSE result (17.7  6.4 h vs. 18.0  5.6 h, p 
NS).
Clinical outcome. The follow-up was 100% complete.
Although discharge was planned, 7/377 (1.8%) patients
remained in the hospital for further evaluation after DSE
was performed; two of these patients underwent revascular-
ization during hospitalization, and one patient was eventu-
ally diagnosed with UA and treated medically. During the
subsequent six-month follow-up, two patients died of car-
diac cause, two had a nonfatal AMI, seven were rehospital-
ized for UA, and another eight patients underwent revas-
cularization. Thus, 22/377 (5.8%) patients reached a
combined end point (Table 2).
Variables associated with outcome. Clinical variables as-
sociated with combined end point (univariate analysis)
during follow-up were age 65 years (p  0.008); a history
of documented coronary artery disease (p  0.001); and
prior use of beta-blocker (p  0.0001), nitrate (0.004), or
aspirin (p 0.004). A positive DSE was associated with the
combined end point (p  0.0001) (Table 3).
Multivariate analysis. The variables associated with com-
bined end point in the univariate analysis were compared






Cardiac death 1 1
Nonfatal AMI 2 0
Rehosp-UA 2 6
Primary end point 5 7
PTCA 2 4
CABG 1 3
Combined end point* 8 14
*Combined end point defined as cardiac death, nonfatal myocardial infarction,
rehospitalization for AMI, or coronary revascularization procedure. Positive DSE
defined as the occurrence of new wall motion abnormality in at least one segment.
AMI  acute myocardial infarction; CABG  coronary artery bypass grafting;
DSE  dobutamine stress echocardiography; PTCA  percutaneous transluminal
coronary angioplasty; Rehosp-UA  rehospitalization for unstable angina.
Table 3. Frequencies and Odds Ratios of the Combined End Point According to the Presence
of a Characteristic
Combined End Point Odds Ratio (95% CI) p Value
Age  65 yrs 11/92 (12.0) 3.4 (1.4–8.1) 0.008
Age  65 yrs 11/285 (3.9) –
Male 13/217 (6.0) 1.1 (0.4–2.6) NS
Female 9/160 (5.6) –
Diabetes mellitus 3/36 (8.3) 1.5 (0.4–5.5) NS
No diabetes mellitus 19/341 (5.6) –
Hypertension 9/144 (6.3) 1.1 (0.5–2.7) NS
No hypertension 13/233 (5.6) –
Documented CAD 11/77 (14.3) 4.4 (1.8–10.5) 0.001
No documented CAD 11/300 (3.7) –
Currently smoking 8/140 (5.7) 1.0 (0.4–2.4) NS
Non-smoking 14/237 (5.9)
Family history of CAD 12/193 (6.2) 1.2 (0.5–2.7) NS
No family history of CAD 10/184 (5.4)
Beta-blocker 15/104 (14.4) 6.4 (2.5–16.2) 0.0001
No beta-blocker 7/273 (2.6) –
Nitrate 8/50 (16.0) 4.3 (1.7–10.8) 0.004
No nitrate 14/327 (4.3) –
Aspirin 14/123 (11.4) 4.0 (1.6–9.7) 0.004
No aspirin 8/254 (3.1) –
Calcium antagonist 6/56 (10.7) 2.3 (0.9–6.1) NS
No calcium antagonist 16/321 (5.0) –
Statin 6/66 (9.1) 1.8 (0.7–4.9) NS
No statin 16/311 (5.1) –
ACE inhibitor 3/43 (7.0) 1.2 (0.4–4.4) NS
No ACE inhibitor 19/334 (5.7) –
Nondiagnostic electrocardiogram 11/150 (7.3) 1.6 (0.7–3.7) NS
Normal electrocardiogram 11/227 (4.8) –
Positive DSE 8/26 (30.8) 10.7 (4.0–28.8) 0.0001
Negative DSE 14/351 (4.0) –
Values are all n (%) unless otherwise indicated. A p value of 0.05 was considered statistically significant.
ACE  angiotensin-converting enzyme; CAD  coronary artery disease; CI  confidence interval; DSE  dobutamine
stress echocardiogram.
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using multivariate stepwise logistic regression analysis (Ta-
ble 4). A positive DSE had independent prognostic value,
both for the primary end point (odds ratio, 6.2; 95% CI, 1.6
to 24.3) and for the combined end point (odds ratio, 7.1;
95% CI, 2.5 to 20.2). Prior use of a beta-blocker was the
only independent clinical predictor for the combined end
point (odds ratio, 4.6; 95% CI, 1.7 to 12.1) (Table 4). There
were no clinical predictors for the primary end point.
DISCUSSION
This study demonstrates that predischarge DSE has impor-
tant, independent prognostic value in low-risk chest pain
patients with a normal or nondiagnostic ECG, an unevent-
ful observation period at the cardiac emergency department,
and a negative serial cardiac troponin T. The incidence of
death or nonfatal AMI at six months was low: 1.1% (4/377).
The total cardiac event rate was 8/26 (30.8%) in patients
with a positive DSE and 14/351 (4.0%) in patients with a
negative DSE (p  0.0001).
Chest pain patients with serial negative troponin T. The
prognostic value of a negative cardiac troponin in patients
with chest pain at the emergency room was previously
described by Hamm et al. (10) who reported that, after
excluding unstable coronary artery disease and noncardiac
disease by a standard rule-out protocol, patients with a
negative troponin T had a 1.1% incidence of cardiac death
or nonfatal AMI at 30-day follow-up. Depending on the
clinical presentation, a negative cardiac troponin does not,
by itself, exclude significant disease (22). Indeed, in the
present study, 63 of the 119 patients from the original
cohort of 557 patients that were admitted with a diagnosis
of acute coronary syndrome had a normal serial cardiac
troponin T (Fig. 1). Recently, it was demonstrated that in
69% to 86% of the patients with an acute coronary syn-
drome and major complications during short-term follow-
up, cardiac troponin was negative (11,23,24). The same
holds for long-term follow-up (25). Therefore, in patients
with negative serial troponin T, additional tests are needed
to identify patients at risk for cardiac events in the short and
long term.
Predischarge stress tests. Although recommended in the
American College of Cardiology/American Heart Associa-
tion guidelines (7), the prognostic value of a predischarge
exercise stress test in low-risk chest pain patients has not yet
been studied in great detail. Only two large, but retrospec-
tive, studies showed that a negative or nondiagnostic pre-
discharge exercise ECG was able to identify patients at very
low risk (12,26). Few prior studies have evaluated (dobut-
amine) stress echocardiography for risk-stratification in
patients with chest pain in the emergency room (27–30). In
these small studies, a negative (dobutamine) stress echocar-
diography was associated with a low cardiac event rate (0%
to 4.5%), which was confirmed by our study (14/351
[4.0%]). In the only prospective study, Geleijnse et al. (27)
evaluated DSE in patients with chest pain after ruling out
unstable coronary artery disease. The six-month event rate
was higher than in our study (11/80 [13.8%] vs. 22/377
[7.6%]), which may be explained by the inclusion of
relatively higher risk patients; DSE was more often positive
(36/80 [45.0%] vs. 26/377 [6.7%]), a history of coronary
artery disease was present more often (56.3% vs. 20.4%), the
percentage of nondiagnostic ECGs was higher (60% vs.
40%), and the rule-out protocol used serial creatine kinase
measurements instead of serial troponin T. Moreover, DSE
results were not blinded and may have caused a higher
revascularization rate: 12/80 (15.0%) versus 10/377 (2.7%),
of which 7/12 (58.3%) versus 2/10 (20.0%) were in-hospital
revascularizations.
Only one large prospective study (31) showed that, in
patients with negative serial troponin T (0.06 g/l), a
predischarge exercise ECG had prognostic value; the five-
month risk of cardiac death or myocardial infarction was
1/84 (1.2%) in patients with a low-risk exercise test response
and 2/9 (22.2%) in patients with a high-risk exercise test
response. However, this study comprised patients with UA,
i.e., high-risk patients. In our low-risk population, we found
a six-month risk of cardiac death or myocardial infarction of
1/351 (0.3%) in patients with a negative DSE and 3/26
(11.5%) in patients with positive DSE.
Predischarge coronary angiography. In a study evaluating
routine predischarge coronary angiography in patients with
Table 4. Multivariate (Stepwise) Logistic Regression Analysis, Including Clinical Variables
and DSE
Cardiac Death, Nonfatal AMI or UA Combined End Point
Odds Ratio (95% CI) p Value Odds Ratio (95% CI) p Value
Age  65 yrs 2.6 (0.7–9.4) 0.1 2.1 (0.8–5.4) 0.1
Documented CAD NS NS
Aspirin NS NS
Beta-blocker NS 4.6 (1.7–12.1) 0.002
Nitrate 3.1 (0.8–12.3) 0.1 NS
Positive DSE 6.2 (1.6–24.3) 0.009 7.1 (2.5–20.2)  0.0001
Constant 0.01 0.0001 0.02  0.0001
A p value of 0.05 was considered statistically significant.
AMI  acute myocardial infarction; CAD  coronary artery disease; CI  confidence interval; DSE  dobutamine stress
echocardiogram; UA  unstable angina.
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chest pain after ruling out unstable coronary artery disease,
deFillipi et al. (32) showed that the coronary angiogram was
not superior to a predischarge exercise ECG in predicting
risk. It was superior in detecting coronary artery disease,
which resulted in more (but potentially unnecessary) revas-
cularizations (14/123 [11%] vs. 5/125 [4%]). It has been
shown before that revascularization itself has a risk of
procedure-related complications (33). For this reason pre-
discharge coronary angiography without prior ischemia
detection test is not recommended in low-risk chest pain
patients (34).
Independent mechanisms of risk factors. The indepen-
dent prognostic value of DSE in patients with negative
serial troponin T can be explained as follows: troponin T is
a specific marker of myocardial damage. The major mech-
anism in the occurrence of myocardial damage in the setting
of acute coronary syndrome is plaque rupture, superimposed
thrombus formation, and transient decrease of coronary
flow and/or distal embolization of a coronary artery, not
necessarily in combination with a severe coronary artery
stenosis (35). Dobutamine stress (or exercise) induced isch-
emia results from regional supply-demand imbalance of
oxygen in presence of a fixed coronary artery stenosis (36).
Development of regional ischemia may result in transient
segmental myocardial wall motion abnormality, which pre-
cedes ECG changes and angina pectoris, and can be
detected by echocardiography (15). Either one or both
mechanisms may be involved in patients presenting with
chest pain. In our study population, myocardial damage was
ruled out by serial troponin T. In these patients, ischemia
detection by DSE was able to identify patients at high and
at low risk for future cardiac events.
Study limitations. Dobutamine stress echocardiography
could not be performed in 23/404 (5.7%) patients because of
poor acoustic window. This percentage is comparable with
what has been previously reported (5%) (14).
The performance of DSE requires personnel experienced
in the procedure. Therefore, occasionally patients had to
wait until experienced personnel were available. However,
all stress echocardiograms were performed within 24 h after
admission, which was according with the recommendations
outlined in the American College of Cardiology/American
Heart Association guidelines (7) (stress test to be performed
before discharge or within 72 h after discharge).
Financial implications. A true cost analysis comparing the
use of DSE with current clinical practice cannot be per-
formed with our data. However, the results of the present
study and of previous studies indicate that DSE has similar
diagnostic and prognostic accuracy as immediate nuclear
imaging in this patient population. It has been shown that
rule-out protocols using immediate nuclear imaging at a
chest pain center may be cost saving (37,38). Dobutamine
stress echocardiography is more readily available and less
costly than nuclear imaging, and, depending on the proto-
col, may also be cost-saving.
Clinical implications. This is the first prospective study
that evaluated a predischarge DSE in a blinded fashion in
patients with chest pain in whom an acute coronary syn-
drome was ruled out by a standard protocol and a negative
serial troponin T. We showed that, in such patients, a
predischarge DSE had important, independent predictive
value. We conclude that, DSE can be a valuable diagnostic
technique for predischarge risk assessment in patients with
chest pain in addition to a standard rule-out protocol and a
negative serial troponin T.
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